Cisternal talc injection in dog can induce delayed and prolonged arterial constriction resembling cerebral vasospasm morphologically and pharmacologically

Surgical Neurology

Volumn 45, Issue 5, 1996, Pages 442-447

  Nagata, Kazuya ^a   Sasaki, Tomio ^b   Mori, Takashi ^b   Nikaido, Hirofumi ^b   Kobayashi, Eiichi ^b   Kim, Phyo ^b   Kirino, Takaaki ^b  

^a Showa General Hospital   (Japan)

^b NONE

Author keywords

Cerebral vasospasm; cisternal talc injection; experimental model; inflammation; subarachnoid hemorrhage

Indexed keywords

ARGIPRESSIN; NITROPRUSSIDE SODIUM; PAPAVERINE; TALC; URIDINE TRIPHOSPHATE; VERAPAMIL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY CONSTRICTION; ARTERY DIAMETER; ARTICLE; BASILAR ARTERY; BRAIN VASOSPASM; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOG; INTRACISTERNAL DRUG ADMINISTRATION; NONHUMAN; VASCULAR RING;

EID: 0029880703     PISSN: 00903019     EISSN: None     Source Type: Journal    
DOI: 10.1016/0090-3019(95)00455-6     Document Type: Article

References (39)

1. Adler RH, Sayek I. Treatment of malignant pleural effusion: a method using tube thoracostomy and talc. Ann Thorac Surg 1976;22:8-15.
2. Bagley C Jr. Blood in the cerebrospinal fluid. Resultant functional and organic alterations in the central nervous system. A experimental data. Arch Surg (Chicago) 1928;17:18-38.
3. Bocci V. The role of sialic acid in determining the life-span of circulating cells and glycoproteins. Experientia 1976;32:135-40.
4. Cheung ST, McIlhany MP, Lim R, Mullan S. Preliminary characterization of vasocontractile activities in erythrocytes. J Neurosurg 1980;53:37-43.
5. Duff TA, Feilbach JA, Yusuf Q, Scott G. Bilirubin and the induction of intracranial arterial spasm. J Neurosurg 1988;69:593-8.
6. Eldevik OP, Kristiansen K, Torvik A. Subarachnoid hemorrhage and cerebrovascular spasm. Morphological study of intracranial arteries based on animal experiments and human autopsies. J Neurosurg 1981; 55:869-76.
7. Endo S, Suzuki J. Experimental cerebral vasospasm after subarachnoid hemorrhage: development and degree of vasospasm. Stroke 1977;8:702-7.
8. Fein JM, Flor WJ, Cohan SL, Parkhurst J. Sequential changes of vascular ultrastructure in experimental cerebral vasospasm. Myonecrosis of subarachnoid arteries. J Neurosurg 1974;41:49-58.
9. Findlay JM, Weir BKA, Kanamaru K, Espinosa F. Arterial wall changes in cerebral vasospasm. Neurosurgery 1989;25:736-46.
10. Fujiwara S, Kuriyama H. Hemolysate-induced contraction in smooth muscle cells of the guinea pig basilar artery. Stroke 1984;15:503-10.
11. Hammes EM Jr. Reaction of the meninges to blood. Arch Neurol Psychiat 1944;52:505-14.
12. Handa H, Osaka K, Okamoto S. Breakdown products of erythrocytes as a cause of cerebral vasospasm. In: Wilkins RH, ed. Cerebral arterial spasm. Baltimore: Williams & Wilkins, 1980:158-65.
13. Handa Y, Kabuto M, Kobayashi H, Kawano H, Takeuchi H, Hayashi M. The correlation between immunological reaction in the arterial wall and the time course of the development of cerebral vasospasm in a primate model. Neurosurgery 1991;28:542-49.
14. Hayat HA. Basic techniques for transmission electron microscopy. 1st ed. London: Academic Press, 1986: 127-41.
15. Karcioglu ZA, Aran AJ, Holmes DL, Kapicioglu Z, Lopez J. Inflammation due to surgical glove powders in the rabbit eye. Arch Ophthalmol 1988;106:808-11.
16. Khansari N, Fudenberg HH. Phagocytosis of senescent erythrocytes by autologous monocytes: Requirement of membrane-specific autologous IgG for immune elimination of aging red blood cells. Cell Immunol 1983;78:114-21.
17. Khansari N, Fudenberg HH. Immune elimination of autologous senescent erythrocytes by Kupffer cells in vivo. Cell Immunol 1983;80:426-30.
18. Kim P, Sundt TM, Vanhoutte PM. Alterations in endothelium-dependent responsiveness of the canine basilar artery after subarachnoid hemorrhage. J Neurosurg 1988;69:239-46.
19. Kohno K, Sasaki S, Ohue S, Kumon Y, Matsuoka K. Intracellular calcium levels in canine basilar artery smooth muscle following experimental subarachnoid hemorrhage: an electron microscopic cytochemical study. Acta Neuropathol 1991;81:664-69.
20. Kuster JM, Schauer R. Phagocytosis of sialidase-treated rat erythrocytes: evidence for a two-step mechanism. Hoppe-Seyler's Z Physiol Chem 1981;362: 1507-14.
21. McIlhany MP, Johns LM, Leipzig T, Patronas NJ, Brown FD, Mullan SF. In vivo characterization of vasocontractile activities in erythrocytes. J Neurosurg 1983;58:356-61.
22. 4 in experimental cerebral vasospasm. Acta Neuropathol 1991; 81:401-7.
23. Mori T, Nagata K, Ishida T, Sasaki T, Nirei H, Hamada K, Ooami H, Kirino T. FK-506, a new immunosuppressive agent, failed to reduce the cerebral vasospasm after experimental subarachnoid hemorrhage. J Vet Med Sci 1993;55:581-6.
24. Nagata K, Sasaki T, Iwama J, Mori T, Iwamoto S, Nirei H, Hamada K, Kirino T. Failure of FK-506, a new immunosuppressant, to prevent cerebral vasospasm in a canine two-hemorrhage model. J Neurosurg 1993; 79:710-5.
25. Okwuasaba F, Cook D, Weir B. Changes in vasoactive properties of blood products with time and attempted identification of the spasmogen. Stroke 1981; 12:775-80.
26. Osaka K. Prolonged vasospasm produced by the breakdown products of erythrocytes. J Neurosurg 1977;47:403-11.
27. Ozaki N, Mullan S. Possible role of the erythrocyte in causing prolonged cerebral vasospasm. J Neurosurg 1979;51:773-8.
28. Peterson JW, Kwun B-D, Hackett JD, Zervas NT. The role of inflammation in experimental cerebral vasospasm. J Neurosurg 1990;72:767-74.
29. Peterson JW, Roussos L, Kwun B-D, Hackett JD, Owen CJ, Zervas NT. Evidence of the role of hemolysis in experimental cerebral vasospasm. J Neurosurg 1990; 72:775-81.
30. Sasaki T, Asano T, Takakura K, Sano K, Kassell NF. Nature of the vasoactive substance in CSF from patients with subarachnoid hemorrhage. J Neurosurg 1984;60:1186-91.
31. Sasaki T, Kassel NF, Yamashita M. Barrier disruption in the major cerebral arteries following experimental subarachnoid hemorrhage. J Neurosurg 1985;63:433-40.
32. Seifert V, Stolke D, Reale E. Ultrastructural changes of the basilar artery following experimental subarachnoid haemorrhage. A morphological study on the pathogenesis of delayed cerebral vasospasm. Acta Neurochir (Wien) 1989;100:164-71.
33. Sheikh KMA, Duggal K, Refson M, Gignac S, Rowden G. An experimental histopathologic study of surgical glove powders. Arch Surg 1984;119:215-9.
34. Smith RR, Clower BR, Peeler DF Jr, Yoshioka J. The angiopathy of subarachnoid hemorrhage: Angiographic and morphologic correlates. Stroke 1983;14: 240-5.
35. Tanaka Y. Role of histamine in the occurrence of talc-induced pleurisy. J Kyoto Pref Univ Med 1986;95: 639-51.
36. Yamashima T, Yamamoto S. Cerebral arterial pathology in experimental subarachnoid hemorrhage. J Neurosurg 1983;58:843-50.
37. Yanamoto H, Kikuchi H, Okamoto S, Nozaki K. Cerebral vasospasm caused by cisternal injection of polystyrene latex beads in rabbits is inhibited by a serine protease inhibitor. Surg Neurol 1994;42:374-81.
38. Wilkinson PC. Recognition and response in mononuclear and granular phagocytes. A review. Clin Exp Immunol 1976;25:355-66.
39. Wise BL. The reaction of the brain, spinal cord and peripheral nerves to talc and starch glove powders. Ann Surg 1955;142:967-72.